Both microarray data of ERBB4 (Fig. 1e) and Olig2 (Fig. 1f), two known PN subtype signature genes, show significantly different expression levels between grade III and IV gliomas in GDS1815 dataset (p = 0.01 and 0.005, respectively). This evidence concerns the gene ERBB4 and central nervous system cancer.